Fifty-five isolates of coagulase-negative staphylococci from blood were identified four times each by using the API Staph-Ident (API-SI) system to determine the identification reproducibility of the system. Identifications were determined by using both Version 1 and Version 2 of the API-SI Profile Index. The 75 to 100% reproducibility levels, including reproducible nonidentifications, were 98.2% for Version 1 and 96.4% for Version 2. Version 1 gave an identification for 92.5% of the isolates with a 75 to 100% reproducibility, while
Version 2 gave an identification for 100% of the isolates with a 75 to 100% reproducibility. The reproducibility of the API-SI identifications of coagulase-negative staphylococci from blood was good.
There has been a debate in the literature about the value of identifying coagulase-negative staphylococci from normally sterile body sites, especially blood (4, 5, 7, 11) . If a given laboratory has decided that it is valuable to identify coagulase-negative staphylococci to species level, it must choose between conventional biochemicals and commercial kits.
One commercial kit that is available for the identification of coagulase-negative staphylococci is the API Staph-Ident (API-SI) (Analytab Products, Plainview, N.Y.). The advantage of this kit is that it requires only a 5-h incubation period. The API-SI has been evaluated by a number of investigators (1-3, 6, 8-10) . In studies using fresh clinical isolates of coagulase-negative staphylococci, the accuracy of the API-SI has ranged from 65.3% without the use of recommended supplemental tests (8) to 92.7% with the use of recommended supplemental tests (2) . For one study using stock cultures of coagulase-negative staphylococci, an accuracy rate of 95% was reported (10) . For other studies using fresh clinical isolates of coagulase-negative staphylococci, accuracies ranging from 79.2 to 90.4% were reported (1, 3, 6, 9) . Although the accuracy is not as high as that obtained with kits for the identification of gram-negative enteric bacilli, the API-SI appears to be a useful system for laboratories that have decided that the identification of coagulase-negative staphylococci is important. The API-SI should not be used to identify Staphylococcus aureus, as this is easily accomplished by less expensive means, such as the coagulase, latex agglutination, and thermonuclease tests.
However, none of the previous reports on the API-SI (1-3, 6, 8-10) have contained reproducibility data. This presents a problem when the API-SI is used to identify coagulasenegative staphylococci from blood cultures. When multiple blood cultures from the same patient are found to be positive for coagulase-negative staphylococci and the API-SI identifications differ, are the isolates truly different or not? If the antimicrobial susceptibility patterns are different, the isolates are assumed to be different. If the susceptibility patterns are the same, are the isolates different or is this a reproducibility problem due to the lower-than-desired accuracy of the API-SI?
To determine whether the API-SI gave reproducible re- Standard biochemical tests to determine the accuracy of the API-SI identification of the coagulase-negative staphylococcus isolates were not performed. Table 1 lists the number of isolates and identifications which were obtained with Version 1 of the API-SI Profile Index. Table 2 lists the number of isolates and identifications which were obtained with Version 2 of the API-SI Profile Index. The major differences between Version 1 and Version 2 results were the elimination of the "no identification" category and the increase in the number of isolates giving 100% reproducibility. Of the 11 isolates identified as Staphylococcus saprophyticus by Version 1, 9 were identified as Staphylococcus hominis and one was identified as Staphylococcus warneri by Version 2. Of the four isolates not identified by Version 1, two were identified as Staphylococcus simulans, one was identified as Staphylococcus epidermidis, and one was identified as S. warneri (50% reproducibility) by Version 2.
It was noted that there were problems in reading certain API-SI test reactions, which led to a lack of reproducibility of biotype codes but did not necessarily result in a change of the final identification. These problems were encountered by all of the medical technologists involved in the study. The most problematic tests were alkaline phosphatase, "-glucosidase, and arginine utilization, which accounted for 9, 8, and 22 biotype changes, respectively. No other test resulted in more than two biotype changes. The results of this study suggest that the reproducibility of API-SI species identification of coagulase-negative staphylococci from blood was good. The 75 to 100% reproducibility levels, including reproducible nonidentifications, of the API-SI for 55 coagulase-negative staphylococcus isolates were 98.2% for Version 1 and 96.4% for Version 2. Version 1 gave an identification for 50 of 54 (92.5%) coagulasenegative staphylococcus isolates with a 75 to 100% reproducibility. Version 2 gave an identification for 53 of 53 (100%) of the coagulase-negative staphylococcus isolates with a 75 to 100% reproducibility. Even though species identification was reproducible, the API-SI biotype numbers were not. Biotype reproducibility could be improved if the positive and negative reactions for the alkaline phosphatase, ,-glucosidase, and arginine utilization tests could be made less ambiguous. Therefore, blood isolates of coagulasenegative staphylococci with different API-SI identifications from the same patient should be considered truly different even if the susceptibility patterns are identical.
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